A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the âexclusiveâ use of e-cigarettes and chronic obstructive pulmonary disease (COPD), as well as high blood pressure in a sub-group of adults 30 to 70 years of age.Â
In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, QRICH1, which could become a target for drugs to dial up or down the activation of T cells to fight cancers and autoimmune diseases.
A Johns Hopkins Medicine Organ Transplant Story
Scientists at Johns Hopkins Medicine say they have discovered how a group of proteins linked to Parkinsonâs disease and amyotrophic lateral sclerosis act as âguardiansâ of mitochondria, small organelles, or subunits, within a cell that make and store energy and are found in almost all plants and animals.
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic âmarksâ in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may keep at least a temporary âmemoryâ of those cancer-linked marks.
Researchers are studying messenger RNAâs potential to treat and prevent an array of serious conditionsâincluding cancer.
By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.
A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.
Gabryelle âGabbyâ Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center on her basketball team, is known for getting rebounds on the basketball court. However, only about a year ago, she was rebounding from serious complications of multiple sclerosis (MS).
Two researchers from the Johns Hopkins University School of Medicine have been elected 2024 Fellows of the American Association for the Advancement of Science (AAAS), the largest scientific society in the world and publisher of the Science family of journals.
In the spring, the grass turns green, trees begin to bud and flowers blossom again. However, the change in season also can bring runny and stuffy noses, sneezes and itchy, watery eyes.
Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have identified a potential new gene target that could be edited to treat sickle cell disease, an inherited blood disorder marked by sickle-shaped red blood cells that cause intense pain and shorten lifespans.
Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage invaders â by seizing genetic material from weakened, dormant phages and using it to âvaccinateâ themselves to elicit an immune response.
In a recent, cross-institutional study partially funded by the National Institutes of Health, researchers report that healthy human airways are at higher risk for dehydration and inflammation when exposed to dry air, an occurrence expected to increase due to global warming.
Johns Hopkins Childrenâs Center pediatric infectious diseases specialists Aaron Milstone, M.D., M.H.S., and Erica Prochaska, M.D., M.H.S., M.H.S., are available to discuss the following topics related to measles.
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns Hopkins Medicine found that 40% of adults with chronic pain experienced âclinically significant depression and anxiety.â Among those most at risk, the analysis showed, were women, younger adults and people with fibromyalgia.
Johns Hopkins University engineers have developed a pioneering prosthetic hand that can grip plush toys, water bottles, and other everyday objects like a human, carefully conforming and adjusting its grasp to avoid damaging or mishandling whatever it holds.
Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost those proteins, theyâve created experimental versions of a genetic âtailâ that attaches to so-called mRNA molecules that churn out the proteins.
Audacyâs 36th annual Mix 106.5 Radiothon last week raised $1,141,307.64 for Johns Hopkins Childrenâs Center. The final total was announced on Mix 106.5 (WWMX-FM) on Monday, March 3. During the event, Mix 106.5 broadcast live from the Childrenâs Center for a total of 26 hours.
New research, led by Johns Hopkins Childrenâs Center investigators and sponsored by the National Institutes of Healthâs (NIH) National Institute of Allergy and Infectious Diseases (NIAID), finds that omalizumab, a U.S. Food and Drug Administration-approved (FDA) injectable drug for food allergies, performed better than oral immunotherapy. A subsequent phase of the study also found that patients may be able to introduce allergenic foods into their diets after stopping the medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right